Biocon to Produce Devices for Insulin Portfolio
Biocon opens a facility to manufacture devices for its insulin portfolio. The facility is said to be spread over 10,000 […]
Say something
Tags: Biocon, biology, diabetes, Diabetes mellitus type 1, Eli Lilly and Company, Endocrine system, Health/Medical/Pharmaceuticals, healthcare, India, insulin, Insulin glargine, insulin products, insulin-dependent diabetes, Kiran Mazumdar-Shaw, media reports, medicine, pen like delivery devices, Peptide hormones, Recombinant proteins
FIT 2.0 Recommendations released to Promote Correct Insulin Injection Technique
FIT Insulin Injection Day was observed in Delhi, with the release of new recommendations for insulin injection usage and a […]
-
-
Flipkart Health+ App Launched
06-04-2022
